Todd Rice Archives
Study of two sepsis interventions finds identical outcomes
Feb. 2, 2023—Vanderbilt University Medical Center had a leading role in a large national study designed to compare two early interventions in the treatment of patients with sepsis, the body’s severe response to an uncontrolled infection.
Alarming number of pregnant COVID-19 patients hospitalized in August
Sep. 1, 2021—Vanderbilt University Hospital treated 39 pregnant patients hospitalized with active COVID-19 infections in August, 10 of whom were admitted to the intensive care unit (ICU).
Convalescent plasma improved survival in COVID-19 patients with blood cancers
Feb. 5, 2021—Treatment with convalescent plasma vastly improved the survival rate of patients hospitalized for COVID-19 who also had hematologic malignances that compromise the immune system, according to new data released by the COVID-19 and Cancer Consortium (CCC19).
Vanderbilt University Medical Center begins giving COVID-19 vaccines to front-line caregivers
Dec. 17, 2020—Vanderbilt University Medical Center began vaccinating its front-line caregivers for COVID-19 on Thursday, Dec. 17.
Clinical trial to test HIV drugs to treat COVID-19
Oct. 16, 2020—Vanderbilt University Medical Center, in collaboration with the University of Colorado and Beth Israel Deaconess Medical Center in Boston, is leading one of the first “telemedicine” clinical trials to test a potential treatment for COVID-19.
VUMC awarded $34 million to lead nationwide convalescent plasma study
Aug. 21, 2020—Vanderbilt University Medical Center has been awarded a one-year, $34-million grant by the National Center for Advancing Translational Sciences, part of the National Institutes of Health, to conduct a nationwide study of “convalescent plasma” as a treatment for COVID-19.
Rice named to new leadership role for VICTR operations
Jul. 23, 2020—Todd Rice, MD, MSc, has been appointed vice president for Clinical Trial Innovation and Operations in the Vanderbilt Institute for Clinical and Translational Research (VICTR).
Remdesivir helps reduce COVID-19 recovery time: study
Jun. 4, 2020—The investigational antiviral drug remdesivir can shorten the time to recovery in adults hospitalized with COVID-19, according to preliminary results of a clinical trial published last month in The New England Journal of Medicine.
Vaccine study seeks to halt flu’s most severe side effects
Oct. 9, 2019—Vanderbilt University Medical Center is leading a multicenter national study to evaluate the effectiveness of the influenza vaccine for preventing the flu’s most serious side effects — admission to an intensive care unit (ICU), organ failure and death.
ECMO program expanding to more intensive care units
Sep. 12, 2019—VUMC is expanding its ECMO program from its longtime home in the Cardiovascular Intensive Care Unit (CVICU) to the Medical (MICU) and Trauma Intensive Care units.
Many hands help make wedding dream come true
Oct. 1, 2015—Their wedding date was just weeks away when Caleb Hanby and his fiancée Bethany Davidson rushed to Vanderbilt University Medical Center last Thursday.
Panel examines real-world role of pragmatic research trials
Mar. 12, 2015—The question of what’s different about pragmatic research was aired in a well-attended panel discussion last week in Light Hall sponsored by the Vanderbilt Center for Health Services Research and the Mid-South Clinical Data Research Network (CDRN).
